Previous Close | 48.29 |
Open | 48.04 |
Bid | 48.18 x 2200 |
Ask | 48.31 x 900 |
Day's Range | 47.74 - 48.12 |
52 Week Range | 42.63 - 57.82 |
Volume | |
Avg. Volume | 1,709,008 |
Market Cap | 119.793B |
Beta (5Y Monthly) | 0.44 |
PE Ratio (TTM) | 20.44 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.90 (3.97%) |
Ex-Dividend Date | May 30, 2023 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for SNY
(Bloomberg) -- Potential bidders for Sanofi’s consumer health division are mulling debt packages of about €7.5 billion ($8.16 billion), according to people familiar with the matter, which would make it one of the biggest leveraged buyout financings in recent years.Most Read from BloombergApple Without AI Looks More Like Coca-Cola Than High-Growth TechUS Probing Indian Billionaire Gautam Adani and His Group Over Potential BriberyWhat Does the UAE Get for Its $35 Billion Investment in Egypt?Want t
In this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology industry and the latest trends, then you can take a look at the 5 Most Profitable Biotech Stocks To Invest In. Biotechnology is the riskiest and […]
ASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with eczema, who have previously been treated with Dupixent but did not achieve an adequate response.